Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
6.8%
1w
2.2%
1m
2.0%
3m
0.7%
6m
32.1%
1y
32.1%
all
27.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 504 6.8%
454
553
Company Overview

Sales
722 Cr
Growth: -7.7%
Profit after Tax
168 Cr
Growth: 6.7%
Mid Cap
8,744 Cr
P/E: 52.1x
Industry P/E: 41.6x
Fundamentals

Sales (Cr) ₹ 722
Growth -7.7%
EBITDA 30.7%
P/S 12.1x
Dividend 0.0%
P/E 52.1x
Book Value ₹ 54.3
PEG Ratio -6.8x
ROE 19.3%
P/B 9.3x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.